USE OF COENZYM Q (UBIQUINONE) AND EIKOSAPENTAENSACEAE (EPA) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA AND PSYCHIATRIC OR NEUROLOGICAL RECORDS

摘要

The co-administration of ubiquinone (coenzyme Q) with eicosapentaenoic acid, which may be supplemented with or replaced by one or more of the unsaturated fatty acids gamma-linolenic acid, dihomogamma-linolenic acid, arachidonic acid and stearidonic acid. The fatty acids docosahexaenoic acid and linoleic acid should be present in less than 10%.